Home Search
red blood cell - search results
If you're not happy with the results, please do another search
Vaccinated mothers transfer COVID antibodies via breast milk
A study by the University of Florida finds that vaccinated mothers transfer COVID antibodies to babies via breast milk - suggesting that mothers can "pass on this immunity to their babies".
Apoptosis: A key alternate trigger of carcinogenesis
Chanda Siddoo-Atwal, President and Primary Biochemist of Moondust Cosmetics Ltd., explores apoptosis, a key alternate trigger of carcinogenesis.
A changing landscape for type 1 diabetes
Dr Faye Riley, Senior Research Communications Officer at Diabetes UK, charts a changing landscape for type 1 diabetes.
New mosquito control tools are critical
Leo Braack, Malaria Consortium’s Senior Vector Control Specialist, recounts the ongoing battle against vector-borne diseases and shares why the need for new mosquito control tools has become critical.
Using human models of brain development to understand autism
Dr Kristen Kroll from Washington University School of Medicine discusses new approaches for studying autism and other neurodevelopmental disorders by using human cellular models of brain development.
Study finds hydroxychloroquine most likely toxic to human genome
A study, published in the journal DNA Repair, finds that hydroxychloroquine (HCQ) is potentially toxic to mammals - the drug that was previously elevated to the status of miracle COVID cure in some circles.
Researchers begin work on magnetic male contraceptive
Researchers have created biodegradable, magnetic nanomaterials that reduce the likelihood of lab mice having children for 30 days.
Tailoring the immune system to viral threats
How viral vaccines work and why they are effective in curbing human viral disease - Pamela J. Lein and colleagues discuss in detail.
Acne rosacea: What is brimonidine tartrate gel?
Dr Deborah Lee, Dr Fox Online Pharmacy, tells us all about brimonidine gel as an effective treatment for acne rosacea.
Study highlights importance of second COVID-19 vaccine
Findings from a new study strongly emphasise why the second dose of the COVID-19 vaccine should not be skipped.
What causes periorbital hyperpigmentation and how can you treat it?
Dr Deborah Lee, Dr Fox Online Pharmacy, tells us all about periorbital hyperpigmentation, including what causes it and how it can be treated.
Biobanks to support medical research focus
With the current focus on public health worldwide, Arthur Goudena, Marketing Manager of PHC Europe, explains how one of Europe’s leading biobanks plays a growing role in supporting medical research.
Oxford University launch clinical trial for HIV vaccine
The team will have results to discuss in April, 2022 - they nurse the hope that this HIV vaccine could stop different geographical strains, after 40 years of no cure.
Study reveals 94% of cancer patients react well to COVID vaccine
According to the US and Swiss study, 94% of cancer patients took the COVID vaccine in full and produced antibodies - while seven high-risk patients failed to produce an immune response.
Precision medicine: From bench to clinic
Here, we find out about Yourgene Health, a molecular diagnostics company with products and technologies that enable precision medicine in oncology from bench to clinic.
Animal health: African swine fever
African swine fever is placed under the spotlight here by Prof. Dr. José Manuel Sánchez-Vizcaíno, Full Professor of Animal Health at Universidad Complutense de Madrid.
Bioinformatics focus: Can we break the glycocode?
Frederique Lisacek from SIB Swiss Institute of Bioinformatics, provides the computer-based tools for exploring ways of breaking the glycocode.
Scientists say vaccines less effective against Delta variant
According to a new study, the antibodies created by the Pfizer vaccine are on average less effective against the Delta variant.
What is a bacterium?
Ann G. Matthysse, from the University of North Carolina’s Department of Biology, delves into an exploration of harmful and useful bacteria for elementary school students.
COVID patients have antibodies “11 months after first symptoms”
Scientists are explaining that antibody production doesn't stop, it simply plateaus - in some people, COVID antibodies exist "11 months after first symptoms".
